Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-21

Clinical Trial Update: Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort

View source ↗

Summary

A real-world multicenter cohort study evaluating the use of Hemospray (TC-325) for treating gastrointestinal bleeding, including ulcer- and tumor-related bleeds…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemospray (TC-325)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Gastrointestinal Hemorrhage, Ulcer Hemorrhage | Status: COMPLETED